Abstract:Lele Yu, Binhai Zhang, Hu Wan Department II of Infectious Diseases, Hangzhou Xixi Hospital, Hangzhou Sixth People's Hospital, Hangzhou, Zhejiang, 310023, People's Republic of China Correspondence: Hu Wan, Email Introduction: Kaposi sarcoma (KS) incidence has decreased since the initiation of combination antiretroviral therapy (cART), but it remains the most common cancer in people with HIV/AIDS (PWHA). PWHA with advanced immunosuppression who initiate antiretroviral therapy are susceptible to the occurrence of an immune reconstitution inflammatory syndrome (IRIS). Case Presentation: This report covers the case of a 25-year-old male with AIDS-related KS who relapsed after Liposomal Doxorubicin, but recovered well after administration of nab-paclitaxel (Nab-PTX). Conclusion: This is a rare case in choosing Nab-PTX to treat relapsed AIDS-KS and get good feedback. We report the case to provide a possible solution to treat AIDS-KS. Keywords: Kaposi sarcoma, nab-paclitaxel, HIV, case report Kaposi sarcoma (KS) is a multicentric vascular neoplasm of endothelial origin with low-grade malignancy. KS most commonly affects the skin, mucous membrane, lymphatic system, and gastrointestinal tract. 1 With the AIDS epidemic in the 1980s and 1990s, its global incidence increased dramatically. Although its incidence has decreased since the initiation of combination antiretroviral therapy (cART), it remains the most common cancer in people with HIV/AIDS (PWHA). The best current treatment strategy is cART alone or in combination with systemic chemotherapy. 2 ART is responsible for KS improvement and resolution, but new onset (unmasking KS-IRIS) or sudden progression of preexisting KS (paradoxical KS-IRIS) can occur, even in patients with a low degree of immunocompromise. 3 The incidence of KS-related IRIS has been reported to be 6% to 29% depending on the study population and the country. 4 A 25-year-old male presented with dark stools for 9 days. Ulcerated nodules were seen on the roof of the mouth, and black nodules were seen in the eyes and corners of the mouth (Figure 1), which gradually increased over the past 6 months. Neck lymph nodes, axillary lymph nodes, and inguinal lymph nodes were enlargement. Laboratory examination in anti - HIV antibody positive, CD4 T lymphocyte count 2 / mL, HIV RNA - 6.81 * 10 5 IU/mL. Pulmonary Computed Tomography (CT) showed many small patches, nodules, and patchy high-density shadows, with blurred boundaries and uneven density (Figure 2). Gastrointestinal endoscopy showed no obvious abnormalities. One week after admission to the hospital, the patient's orbital skin biopsy showed CD34(+) CDX2(-) D2-40(+) HHV8(+) Ki-67(50%+), positive HHV-8 in skin lesions is the gold standard for identification, which was made a definite diagnosis of Kaposi sarcoma (Figure 3). The patient was treated with Liposomal Doxorubicin (20 mg/m2 IV every three weeks) for Kaposi sarcoma by guidelines. Antiviral therapy with tenofovir, lamivudine, and dolutegravir was initiated at the same time. Figure 1 Ulcerative nodules on the patient's roof of the mouth, and black nodules in corners of the mouth. Figure 2 Computed Tomography (CT) of the lungs showed many small patches, nodules, and patchy high-density shadows, with blurred boundaries and uneven density ( A ). After six months of treatment, CT of the lung condition improved ( B ). Figure 3 The patient's orbital skin biopsy:CD34(+) CDX2(-) D2-40(+) HHV8(+) Ki-67(50%+). After receiving 8 cycles of chemotherapy treatments, the patient's lung condition and mouth ulcerative nodules improved slowly. CD4 T lymphocyte count increased to 82/mL, HIVRNA <100 IU/mL. However, A new growing neoplasm was seen in the little toe of the left foot(Figure 4). Magnetic resonance imaging (MRI) of the left foot revealed the joint and component bone morphology and signal were as usual, and no changes were observed in the joint space. The morphology and signal intensity of peripheral ligaments, muscle groups, tendons, and tendon sheaths were not changed. There was no obvious abnormality in the arch morphology. The lateral soft tissue of the left foot was swollen. The left foot skin biopsy immunohistochemical showed CD34(+), EBV(-), ERG(+), and HHV8(+), which was taken to suggest Kaposi sarcoma. Considering that the patient was an allergy sufferer, we changed the chemotherapy regimen to albumin-bound paclitaxel (260mg/m2, every three weeks). Up to now, after 3 cycles of chemotherapy, the patient's new neoplasm of the left foot regressed almost completely(Figure 5). The CD4 T lymphocyte cell counts slowly increased to 188/mL, and viral loads remained below the detectable level. The entire diagn -Abstract Truncated-

HIV-associated CD8+ T-cell Skin Infiltrative Disease and EBV-associated Polymorphic B-cell Lymphoproliferative Disorder in an AIDS Patient Who Improved Dramatically with Antiretroviral Therapy Alone

Epstein-Barr virus associated hepatic smooth muscle tumor in a patient with acquired immunodeficiency syndrome A case report

[Spontaneous regression of HIV-associated EBV-positive mucocutaneous ulcer due to immune reconstruction with antiretroviral therapy]

Drug-induced Erythroderma in Patients with Acquired Immunodeficiency Syndrome.

Skin Diseases in the Era of Highly Active Antiretroviral Therapy: A Retrospective Study of 534 Patients

Human immunodeficiency virus-associated vacuolar encephalomyelopathy with granulomatous-lymphocytic interstitial lung disease improved after antiretroviral therapy: a case report

Acquired ichthyosis in concomitant HIV-1 and HTLV-II infection: a new association with intravenous drug abuse

Cutaneous findings associated with HIV disease including AIDS: experience from Sub Saharan Africa.

Aplastic Anemia with Epstein-Barr Virus Reactivation after Anti-thymocyte Globulin Therapy

Skin disease in homosexual patients with Acquired Immune Deficiency Syndrome (AIDS) and lesser forms of human T cell Leukaemia Virus (HTLV III) disease

Kikuchi-Fujimoto lymphadenitis in a patient with human immunodeficiency virus infection: The importance of precision pathology

BI26 HIV-associated sarcoidosis as a manifestation of immune reconstitution inflammatory syndrome

Hodgkin's Lymphoma after Initiation of Antiretroviral Therapy in a Patient from India

Epstein-Barr Virus-Associated Lymphomatoid Papules: A Sign of Immunosuppression Resembling Lymphomatoid Papulosis

Nab-Paclitaxel for Relapsed AIDS-Related Kaposi Sarcoma -A Case Report

Case report: Bullous pemphigoid in HIV-1-positive patients: interplay or coincidence? A case series and review of the literature

A human immunodeficiency virus-seronegative acquired immunodeficiency syndrome patient with opportunistic infections: A case report

HIV Patients Developing Primary CNS Lymphoma Lack EBV-Specific CD4+ T Cell Function Irrespective of Absolute CD4+ T Cell Counts

PB2142: CLINICAL CHARACTERISTICS AND OUTCOMES OF NEWLY DIAGNOSED PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED LYMPHOMA ADMINISTERED HIGHLY ACTIVE ANTIRETROVIRAL THERAPY

Pathologically Complete Remission to Combination of Invariant NK T Cells and Anti-Cd20 Antibody in a Refractory HIV+ Diffuse Large B-cell Lymphoma Patient.

Clinical Characteristics and Outcomes of Newly Diagnosed Patients with Human Immunodeficiency Virus-Associated Lymphoma Administered Highly Active Antiretroviral Therapy: Central and Western China AIDS Lymphoma League 001 Study (Cw-Call 001).